Valuation: Cipla Limited

Market Cap 1,157B 12.09B 10.36B 9.69B 8.87B 16.65B 16.87B 115B 44.66B 581B 45.41B 44.42B 1,922B P/E 2027 *
27.9x
P/E 2028 * 22.5x
Enterprise Value 1,051B 10.98B 9.41B 8.8B 8.06B 15.12B 15.32B 104B 40.56B 528B 41.24B 40.35B 1,746B EV / Sales 2027 *
3.39x
EV / Sales 2028 * 2.95x
Free-Float
68.87%
Yield 2027 *
0.91%
Yield 2028 * 1.03%
1 day-0.40%
1 week-1.23%
Current month-2.78%
1 month-0.02%
3 months+2.16%
6 months+6.79%
Current year-5.23%
1 week 1,408.6
Extreme 1408.6
1,449
1 month 1,366.1
Extreme 1366.1
1,491.2
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,673
3 years 1,132
Extreme 1132
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 2026-03-31
President - 2026-05-17
Director of Finance/CFO - 2026-07-23
Director TitleAgeSince
Chairman 90 1972-07-20
Director/Board Member 72 2014-07-24
Director/Board Member 71 2021-06-29
Date Insider Type Main position Quantity % Market Cap.
8/22/24 Sell 2,000 0.0002%
8/14/24 Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.40%-1.23%-10.08%+16.08% 12.09B
-0.08%-1.43%+15.99%+67.26% 47.71B
-3.21%+1.37%+52.36%+125.75% 40.3B
+1.11%-1.34%+13.61%+71.49% 11.68B
0.00%+0.58%+30.65%+148.80% 9.19B
-0.39%-0.92%+19.81%+39.54% 7.57B
-1.35%+0.74%+47.03%-11.93% 7.24B
-0.64%-0.02%+19.42%+199.06% 6.84B
-5.36%-6.36%-36.28%+18.28% 5.42B
-0.51%-0.90%+37.01%+103.41% 4.75B
Average -1.08%-1.09%+18.95%+77.78% 15.28B
Weighted average by Cap. -1.14%-0.58%+24.83%+84.03%

Financials

2027 *2028 *
Net sales 310B 3.24B 2.77B 2.6B 2.38B 4.46B 4.52B 30.67B 11.96B 156B 12.16B 11.9B 515B 347B 3.63B 3.11B 2.91B 2.66B 5B 5.06B 34.37B 13.4B 174B 13.63B 13.33B 577B
Net income 41.36B 432M 370M 346M 317M 595M 603M 4.09B 1.6B 20.78B 1.62B 1.59B 68.72B 51.42B 537M 460M 431M 394M 740M 750M 5.09B 1.98B 25.83B 2.02B 1.97B 85.43B
Net Debt -106B -1.11B -950M -889M -813M -1.53B -1.55B -10.5B -4.09B -53.29B -4.16B -4.07B -176B -131B -1.37B -1.18B -1.1B -1.01B -1.89B -1.92B -13.01B -5.07B -66.03B -5.16B -5.05B -218B
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
26-08-21 ₹1,432.20 -0.40% 728,275
26-08-20 ₹1,438.00 +1.13% 327,752
26-08-19 ₹1,422.00 -0.64% 433,654
26-08-18 ₹1,431.10 -0.03% 589,396
26-08-17 ₹1,431.50 -1.28% 756,514
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
1,432.20INR
Average target price
1,509.08INR
Spread / Average Target
+5.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CIPLA Stock